The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

PubChem7263     1H-indol-5-ol

Synonyms: zlchem 359, INDOL-5-OL, SureCN50566, AGN-PC-0DBEUX, CHEMBL404923, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of INDOL-5-OL

 

Psychiatry related information on INDOL-5-OL

 

High impact information on INDOL-5-OL

 

Chemical compound and disease context of INDOL-5-OL

 

Biological context of INDOL-5-OL

 

Anatomical context of INDOL-5-OL

  • In this study, we have investigated the effects of 5-hydroxyindole (5-HI), a positive modulator of the alpha7 nAChR, on GABAergic activity in hippocampal CA1 stratum radiatum interneurons in acute rat brain slices [17].
  • In brief, noxious stimulation was found to decrease 5-hydroxyindole signal in the nucleus raphe magnus; morphine enhanced or attenuated this decrease in the anesthesized rat [18].
  • During the initial phase of group formation, 5-hydroxyindole acetic acid, the metabolite of serotonin, increases in the cerebrospinal fluid of monkeys which become subordinate (all groups), but decreases in monkeys which become dominant (two out of three groups) and shows no changes in intermediate-ranking animals (five out of seven) [19].
  • 5-hydroxyindole causes convulsions and increases transmitter release in the CA1 region of the rat hippocampus [20].
  • The effects of 5-hydroxyindole (5-HI) have been investigated on human alpha 7 nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus oocytes and GH4 cells, on native alpha 7 nAChRs expressed by IMR-32 cells and on alpha 7 nAChR-mediated events in mossy fibre-granule cell synapses in rat cerebellar slices [21].
 

Associations of INDOL-5-OL with other chemical compounds

 

Gene context of INDOL-5-OL

 

Analytical, diagnostic and therapeutic context of INDOL-5-OL

References

  1. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Rönnblom, L.E., Alm, G.V., Oberg, K.E. Ann. Intern. Med. (1991) [Pubmed]
  2. Allosteric potentiation of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells by 5-hydroxyindole and analogues. van Hooft, J.A., van der Haar, E., Vijverberg, H.P. Neuropharmacology (1997) [Pubmed]
  3. The value of tumor markers in a mixed tumor, mucinous and neuroendocrine carcinoma of the ovary. Ngan, H.Y., Collins, R.J., Wong, L.C., Chan, S.Y., Ma, H.K. Gynecol. Oncol. (1989) [Pubmed]
  4. "Peripheral" tetrahydrobiopterin deficiency with hyperphenylalaninaemia due to incomplete 6-pyruvoyl tetrahydropterin synthase deficiency or heterozygosity. Niederwieser, A., Shintaku, H., Leimbacher, W., Curtius, H.C., Hyànek, J., Zeman, J., Endres, W. Eur. J. Pediatr. (1987) [Pubmed]
  5. Normal 5-hydroxyindole excretion in the presence of carcinoid syndrome. Wiles, P., Hampton, K., Dean, H., Feely, M. Irish medical journal. (1987) [Pubmed]
  6. Neural control of predatory aggression in wild and domesticated animals. Nikulina, E.M. Neuroscience and biobehavioral reviews. (1991) [Pubmed]
  7. Lesion of serotonergic neurons antagonizes clonidine induced suppression of avoidance behavior and locomotor activity in rats. Kostowski, W., Plaznik, A., Pucilowski, O., Bidzinski, A., Hauptmann, M. Psychopharmacology (Berl.) (1981) [Pubmed]
  8. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Braida, D., Paladini, E., Griffini, P., Lamperti, M., Maggi, A., Sala, M. Eur. J. Pharmacol. (1996) [Pubmed]
  9. Serotonin catabolism and the formation and fate of 5-hydroxyindole thiazolidine carboxylic Acid. Squires, L.N., Jakubowski, J.A., Stuart, J.N., Rubakhin, S.S., Hatcher, N.G., Kim, W.S., Chen, K., Shih, J.C., Seif, I., Sweedler, J.V. J. Biol. Chem. (2006) [Pubmed]
  10. Characterization of the structure and reactions of free radicals from serotonin and related indoles. Perez-Reyes, E., Mason, R.P. J. Biol. Chem. (1981) [Pubmed]
  11. A single point mutation confers properties of the muscle-type nicotinic acetylcholine receptor to homomeric alpha7 receptors. Placzek, A.N., Grassi, F., Papke, T., Meyer, E.M., Papke, R.L. Mol. Pharmacol. (2004) [Pubmed]
  12. Changes in the serotonergic system in the main olfactory bulb of rats unilaterally deprived from birth to adulthood. Gómez, C., Briñón, J.G., Orio, L., Colado, M.I., Lawrence, A.J., Zhou, F.C., Vidal, M., Barbado, M.V., Alonso, J.R. J. Neurochem. (2007) [Pubmed]
  13. Elevated urinary levels of 5-hydroxyindole acetic acid and its relationship among levels of plasma follicle stimulating hormone, testosterone and testicular pathology in patients with severe oligospermia and/or azoospermia. Urry, R.L., Cockett, A.T. J. Urol. (1977) [Pubmed]
  14. Iron deficiency in the rat: biochemical studies of fetal metabolism. Mackler, B., Grace, R., Person, R., Shepard, T.H., Finch, C.A. Teratology (1983) [Pubmed]
  15. Biochemical studies on the mechanism of difference in the renal toxicity of 5-hydroxy-L-tryptophan between Sprague Dawley and Wistar rats. Hirai, M., Nakajima, T. J. Biochem. (1979) [Pubmed]
  16. Antioxidant activity of 5-hydroxytryptophan, 5-hydroxyindole, and DOPA against microsomal lipid peroxidation and its dependence on vitamin E. Cadenas, E., Simic, M.G., Sies, H. Free Radic. Res. Commun. (1989) [Pubmed]
  17. Excitation of rat hippocampal interneurons via modulation of endogenous agonist activity at the alpha7 nicotinic ACh receptor. Selina Mok, M.H., Kew, J.N. J. Physiol. (Lond.) (2006) [Pubmed]
  18. Effects of morphine on the electrochemical signal modified by noxious stimuli in the nucleus raphe magnus of anesthetized rats. Taguchi, K., Suzuki, Y. Neuropharmacology (1991) [Pubmed]
  19. Relationship between dominance hierarchy, cerebrospinal fluid levels of amine transmitter metabolites (5-hydroxyindole acetic acid and homovanillic acid) and plasma cortisol in monkeys. Yodyingyuad, U., de la Riva, C., Abbott, D.H., Herbert, J., Keverne, E.B. Neuroscience (1985) [Pubmed]
  20. 5-hydroxyindole causes convulsions and increases transmitter release in the CA1 region of the rat hippocampus. Mannaioni, G., Carpenedo, R., Moroni, F. Br. J. Pharmacol. (2003) [Pubmed]
  21. 5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices. Zwart, R., De Filippi, G., Broad, L.M., McPhie, G.I., Pearson, K.H., Baldwinson, T., Sher, E. Neuropharmacology (2002) [Pubmed]
  22. Pineal gland "magnetosensitivity" to static magnetic fields is a consequence of induced electric currents (eddy currents). Lerchl, A., Nonaka, K.O., Reiter, R.J. J. Pineal Res. (1991) [Pubmed]
  23. Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain. Grilli, M., Raiteri, L., Patti, L., Parodi, M., Robino, F., Raiteri, M., Marchi, M. Br. J. Pharmacol. (2006) [Pubmed]
  24. Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome. Ueda, M., Hamamoto, M., Nagayama, H., Okubo, S., Amemiya, S., Katayama, Y. J. Neurol. Neurosurg. Psychiatr. (2001) [Pubmed]
  25. Effect of lithium administration on rat brain 5-hydroxyindole levels in a possible animal model for mania. Vale, A.L., Ratcliffe, F. Psychopharmacology (Berl.) (1987) [Pubmed]
  26. Effects of chronic restraint stress and estradiol on open field activity, spatial memory, and monoaminergic neurotransmitters in ovariectomized rats. Bowman, R.E., Ferguson, D., Luine, V.N. Neuroscience (2002) [Pubmed]
  27. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome. Quatrini, M., Basilisco, G., Conte, D., Bozzani, A., Bardella, M.T., Bianchi, P.A. Am. J. Gastroenterol. (1983) [Pubmed]
  28. AWD-12-281 (inhaled) (elbion/GlaxoSmithKline). Gutke, H.J., Guse, J.H., Khobzaoui, M., Renukappa-Gutke, T., Burnet, M. Current opinion in investigational drugs (London, England : 2000) (2005) [Pubmed]
  29. Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells. Kooyman, A.R., van Hooft, J.A., Vanderheijden, P.M., Vijverberg, H.P. Br. J. Pharmacol. (1994) [Pubmed]
  30. 5-Hydroxyindole slows desensitization of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells. Kooyman, A.R., van Hooft, J.A., Vijverberg, H.P. Br. J. Pharmacol. (1993) [Pubmed]
  31. Iron deficiency in the rat: biochemical studies of brain metabolism. Mackler, B., Person, R., Miller, L.R., Inamdar, A.R., Finch, C.A. Pediatr. Res. (1978) [Pubmed]
  32. Depressed 5-hydroxyindole levels associated with hyperactive and aggressive behavior. Relationship to drug response. Greenberg, A.S., Coleman, M. Arch. Gen. Psychiatry (1976) [Pubmed]
  33. Effects induced by the electrical stimulation of the nucleus raphe dorsalis upon hypothalamic release of 5-hydroxyindole compounds and sleep parameters in the rat. Houdouin, F., Cespuglio, R., Jouvet, M. Brain Res. (1991) [Pubmed]
  34. Hippocampal 5-HT1A receptor binding site densities, 5-HT1A receptor messenger ribonucleic acid abundance and serotonin levels parallel the activity of the hypothalamo-pituitary-adrenal axis in rats. Burnet, P.W., Mefford, I.N., Smith, C.C., Gold, P.W., Sternberg, E.M. Behav. Brain Res. (1996) [Pubmed]
  35. The dopamine D2 receptor antagonist sulpiride causes long-lasting serotonin release. Nakazato, T., Horikawa, H.P., Akiyama, A. Eur. J. Pharmacol. (1998) [Pubmed]
 
WikiGenes - Universities